Point-Counterpoint: The Need for Do-It-Yourself (DIY) Open Source (OS) Automated Insulin Delivery (AID) Systems in Type 1 Diabetes Management
Study context
- Population
- People with T1D using open-source or commercial AID systems
- Comparison
- Open-source AID vs commercial AID systems
Methodological detailsPerspectives of a person with T1D who uses and has developed Open-Source AID (OS-AID), a US physician-researcher conducting trials for commercial AID, and an endocrinologist with T1D using both systems
- Perspectives of a person with T1D who uses and has developed OS-AID, a US physician-researcher conducting trials for commercial AID, and an endocrinologist with T1D using both systems
Main finding
As reported in the abstract
- Point and counterpoint perspectives on safety and efficacy, regulation and support, user choice and flexibility, access and affordability, and patient and provider education for OS-AID and commercial AID systems
- Tens of thousands of people with diabetes still choose OS-AID despite commercial options in some countries
Original publication
Point-Counterpoint: The Need for Do-It-Yourself (DIY) Open Source (OS) AID Systems in Type 1 Diabetes Management. Diabetes Technol Ther. Published 13 May 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →